Regulating Unapproved Drugs in the US: the Role of DESI and FDA Approval Pathways
Crossref DOI link: https://doi.org/10.1007/s12247-025-10332-w
Published Online: 2026-01-17
Published Print: 2026-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rao, Manasa
Shetty, Nisha N.
Hegde, Vignesh
Sreedhar, D.
Pallavi, K.
Text and Data Mining valid from 2026-01-17
Version of Record valid from 2026-01-17
Article History
Received: 6 August 2025
Accepted: 18 December 2025
First Online: 17 January 2026
Declarations
:
: The authors declare no competing interests.